Content
05/15/2025
Oakdale, MN USA
Alpheus Medical
completed $52 million Series B Round funding. Investors include
Samsara BioCapital (lead), HealthQuest Capital (lead), BrightEdge, Action Potential Venture Capital, OrbiMed Advisors, Brain Tumor Investment Fund, Sontag Innovation Fund.
About
Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers. The company’s lead product utilizes a novel, non-invasive drug device combination for outpatient treatment of glioblastoma multiforme (GBM). Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from BrightEdge, the impact investment and venture capital arm of the American Cancer Society, and National Brain Tumor Society.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
